SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-17-004966
Filing Date
2017-05-12
Accepted
2017-05-12 16:16:30
Documents
46
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1701525_10q.htm 10-Q 250295
2 EXHIBIT 31.1 t1701525_ex31-1.htm EX-31.1 10112
3 EXHIBIT 31.2 t1701525_ex31-2.htm EX-31.2 10217
4 EXHIBIT 32.1 t1701525_ex32-1.htm EX-32.1 3735
5 EXHIBIT 32.2 t1701525_ex32-2.htm EX-32.2 3924
  Complete submission text file 0001571049-17-004966.txt   1867350

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cycc-20170331.xml EX-101.INS 248623
7 XBRL SCHEMA FILE cycc-20170331.xsd EX-101.SCH 25605
8 XBRL CALCULATION FILE cycc-20170331_cal.xml EX-101.CAL 28306
9 XBRL DEFINITION FILE cycc-20170331_def.xml EX-101.DEF 62309
10 XBRL LABEL FILE cycc-20170331_lab.xml EX-101.LAB 242452
11 XBRL PRESENTATION FILE cycc-20170331_pre.xml EX-101.PRE 149573
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 17838831
SIC: 2834 Pharmaceutical Preparations